237 related articles for article (PubMed ID: 22052999)
21. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
22. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
[TBL] [Abstract][Full Text] [Related]
23. GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
Martignano F; Gurioli G; Salvi S; Calistri D; Costantini M; Gunelli R; De Giorgi U; Foca F; Casadio V
Dis Markers; 2016; 2016():4358292. PubMed ID: 27594734
[TBL] [Abstract][Full Text] [Related]
24. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
[TBL] [Abstract][Full Text] [Related]
25. In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.
Colciago A; Ruscica M; Mornati O; Piccolella M; Montagnani-Marelli M; Eberini I; Festuccia C; Magni P; Motta M; Negri-Cesi P
Biomed Res Int; 2014; 2014():801473. PubMed ID: 24877132
[TBL] [Abstract][Full Text] [Related]
26. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.
Muthusamy S; Andersson S; Kim HJ; Butler R; Waage L; Bergerheim U; Gustafsson JÅ
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20090-4. PubMed ID: 22114194
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
29. Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer.
Zhang W; Jiao H; Zhang X; Zhao R; Wang F; He W; Zong H; Fan Q; Wang L
Mol Med Rep; 2015 Jul; 12(1):141-6. PubMed ID: 25738352
[TBL] [Abstract][Full Text] [Related]
30. Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
Kollermann J; Kempkensteffen C; Helpap B; Schrader M; Krause H; Muller M; Miller K; Schostak M
BMC Urol; 2006 Jun; 6():15. PubMed ID: 16803634
[TBL] [Abstract][Full Text] [Related]
31. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
[TBL] [Abstract][Full Text] [Related]
32. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.
Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ
Oncogene; 2002 Feb; 21(7):1048-61. PubMed ID: 11850822
[TBL] [Abstract][Full Text] [Related]
33. Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1.
Kanwal R; Pandey M; Bhaskaran N; Maclennan GT; Fu P; Ponsky LE; Gupta S
Mol Carcinog; 2014 Jan; 53(1):8-18. PubMed ID: 22833520
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic CpG Methylation of the Promoter and Reactivation of the Expression of GSTP1 by Astaxanthin in Human Prostate LNCaP Cells.
Yang Y; Fuentes F; Shu L; Wang C; Pung D; Li W; Zhang C; Guo Y; Kong AN
AAPS J; 2017 Mar; 19(2):421-430. PubMed ID: 27913949
[TBL] [Abstract][Full Text] [Related]
35. Lycopene and apo-10'-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells.
Liu AG; Erdman JW
Biochem Biophys Res Commun; 2011 Sep; 412(3):479-82. PubMed ID: 21839064
[TBL] [Abstract][Full Text] [Related]
36. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
[TBL] [Abstract][Full Text] [Related]
37. GSTP1 CpG island hypermethylation for DNA-based detection of occult tumor cells in surgical margins after radical prostatectomy.
Jentzmik F; Krause H; Reichelt U; Schrader AJ; Schrader M; Baumunk D; Cash H; Miller K; Schostak M
World J Urol; 2012 Aug; 30(4):541-6. PubMed ID: 21947551
[TBL] [Abstract][Full Text] [Related]
38. Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis.
Zhou X; Jiao D; Dou M; Chen J; Li Z; Li Y; Liu J; Han X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1939-1948. PubMed ID: 31263949
[TBL] [Abstract][Full Text] [Related]
39. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
40. Gene promoter methylation in prostate tumor-associated stromal cells.
Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
